Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies. | Iran J Immunol | 2022 | 36190382 | PubTator, text mining | PubMed |
| The gut microbiota-bile acid axis: A potential therapeutic target for liver fibrosis. | Front Cell Infect Microbiol | 2022 | 36189347 | PubTator, text mining | PubMed |
| Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice. | JHEP Rep | 2022 | 36160754 | PubTator, text mining | PubMed |
| Fc receptor-like 5 gene polymorphisms and mRNA expression are associated with liver fibrosis in chronic hepatitis B. | Front Microbiol | 2022 | 36160227 | PubTator, text mining | PubMed |
| Hepatitis B and circadian rhythm of the liver. | World J Gastroenterol | 2022 | 36158265 | PubTator, text mining | PubMed |
| Fat Malabsorption and Ursodeoxycholic Acid Treatment in Children With Reduced Organic Solute Transporter-α (SLC51A) Expression. | JPGN Rep | 2022 | 36148443 | PubTator, text mining | PubMed |
| Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions. | Pharmaceuticals (Basel) | 2022 | 36145347 | PubTator, text mining | PubMed |
| Medical Advances in Hepatitis D Therapy: Molecular Targets. | Int J Mol Sci | 2022 | 36142728 | PubTator, text mining | PubMed |
| In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators. | Int J Mol Sci | 2022 | 36142670 | PubTator, text mining | PubMed |
| Common and Rare PCSK9 Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study. | Int J Mol Sci | 2022 | 36142332 | PubTator, text mining | PubMed |
| Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B. | Biomedicines | 2022 | 36140311 | PubTator, text mining | PubMed |
| Use of selective substrates and inhibitors to rapidly characterise batches of cryopreserved primary human hepatocytes for assessment of active uptake liability in drug discovery and development. | Xenobiotica | 2022 | 36121307 | PubTator, text mining | PubMed |
| Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. | Front Microbiol | 2022 | 36118192 | PubTator, text mining | PubMed |
Multimodal perioperative assessment of liver function and volume in patients undergoing hepatectomy for colorectal liver metastasis: a comparison of the indocyanine green retention test, 99mTc mebrofenin hepatobiliary scintigraphy and gadoxetic acid enhanced MRI. | Br J Radiol | 2022 | 36113499 | PubTator, text mining | PubMed |
| Emerging role of mitochondria in response to HBV infection. | J Clin Lab Anal | 2022 | 36111656 | PubTator, text mining | PubMed |
| Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential. | J Med Chem | 2022 | 36111355 | PubTator, text mining | PubMed |
| Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria. | Ann Transl Med | 2022 | 36110988 | PubTator, text mining | PubMed |
| Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA. | J Clin Invest | 2022 | 36106633 | PubTator, text mining | PubMed |
| Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy. | Drug Deliv | 2022 | 36104946 | PubTator, text mining | PubMed |
| N6-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1. | J Virol | 2022 | 36102650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=35